Valtech Cardio

About:

Valtech Cardio is focused on percutaneous annuloplasty ring valve repair for mitral valve regurgitation treatments.

Website: http://www.valtechcardio.com

Top Investors: Peregrine Ventures, NGN Capital

Description:

Valtech Cardio (Israel) a development-stage medical device company focused on minimally invasive percutaneous annuloplasty ring valve repair for the treatment of mitral valve regurgitation.

Total Funding Amount:

$20.2M

Headquarters Location:

Or Yehuda, Tel Aviv, Israel

Founded Date:

2006-01-01

Contact Email:

info(AT)valtech.co.il

Founders:

Amir Gross

Number of Employees:

11-50

Last Funding Date:

2010-03-15

IPO Status:

Private

Industries: